Ghias Babar (CIK 2076862) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-19). Recent activity: Buy BCRX (121,700 shares), Buy BCRX (147,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-19 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Chief Financial Officer | Buy | 121,700 | $0 |
| 2025-07-28 | BIOCRYST PHARMACEUTICALS INC (BCRX) | CFO & Head of Corp Development | Buy | 147,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-19